GlassScriptPhysician profile
Jonathan G Kerrick
NPI 1871565002
$6,303.13
in general payments reported to CMS, 2019-2025
40 companies · $1,905 in 2025
The $1,905 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $540 · 2020: $133 · 2021: $435 · 2022: $792 · 2023: $1,255 · 2024: $1,243 · 2025: $1,905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,402.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,732.46 | 2021-2025 | |
| Ucb, INC. | $687.91 | 2019-2025 | Briviact, Fintepla, Nayzilam |
| Pfizer INC. | $687.11 | 2023-2025 | |
| Melinta Therapeutics, LLC | $456.94 | 2019-2024 | Kimyrsa |
| Argenx US, INC. | $254.92 | 2023-2025 | Vyvgart, Vyvgart Hytrulo |
| Neurelis, INC. | $192.74 | 2022-2023 | Valtoco |
| Biogen, INC. | $186.15 | 2023-2025 | Skyclarys, Vumerity, Tysabri |
| Novartis Pharmaceuticals Corporation | $182.26 | 2019-2025 | |
| Greenwich Biosciences, INC. | $178.65 | 2019-2020 | |
| Lundbeck LLC | $170.06 | 2024-2025 | Vyepti |
| Sk Life Science, INC. | $158.69 | 2022-2025 | |
| Acadia Pharmaceuticals INC | $158.35 | 2022-2025 | Nuplazid, Daybue |
| Lilly USA, LLC | $143.29 | 2019-2025 | Emgality |
| Amneal Pharmaceuticals LLC | $121.59 | 2019-2025 | Crexont, Ongentys 50mg Capsules 30, Rytary |
| Kyowa Kirin, INC. | $104.89 | 2019-2024 | Nourianz |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Kerrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.